Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals

author
created [InstanceEdit:9733013] Stephan, Ralf, 2021-06-01
dbId 9732939
displayName Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
journal Structure
pages 1313-1320.e3
pubMedIdentifier 33152262
schemaClass LiteratureReference
title Malleability of the SARS-CoV-2 3CL Mpro Active-Site Cavity Facilitates Binding of Clinical Antivirals
url http://www.ncbi.nlm.nih.gov/pubmed/33152262
volume 28
year 2020
Cite Us!